Form 4 for EW Edwards Lifesciences
Accepted 2026-05-27 19:28:36 ET · period of report 2026-05-27 · accession 0001225208-26-005610 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-27 19:28 | 2026-05-27 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale | $86.42 | -23.1K | 98.6K | -19% | -$2.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | S | D | 23,145 | $86.42 | 98,611 | I By Trust | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |